← All Agentix CORP filings

Agentix CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
AGTX
Agentix CORP
10-K: Biotech Firm Faces Going Concern Doubts Amidst Funding Challenges and Internal Control Weaknesses
A clinical-stage biotechnology company developing metabolic disease treatments reports no revenue, increasing losses, and significant doubt about its ability to continue operations without substantial new financing.
OTC.Pink
AGTX
Agentix CORP
10-K: Agentix Corp. Files 10-K Report, Details Financials and Development Pipeline
Agentix Corp.'s annual report on Form 10-K reveals a focus on developing metabolic disease treatments, ongoing financial challenges, and a lack of revenue generation.